Literature DB >> 29276272

ISMP Adverse Drug Reactions: Allergic Angina Caused by Fluconazole Rhabdomyolysis Caused by Risperidone High Incidence of Hyponatremia With High-Dose Trimethoprim-Sulfamethoxazole Lithium Carbonate-Induced Hypersalivation Persistent Hemorrhage After Idarucizumab Administration.

Michael A Mancano1,2.   

Abstract

The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), discuss methods of prevention, and promote reporting of ADRs to the US Food and Drug Administration's (FDA) MedWatch program (800-FDA-1088). If you have reported an interesting, preventable ADR to MedWatch, please consider sharing the account with our readers. Write to Dr. Mancano at ISMP, 200 Lakeside Drive, Suite 200, Horsham, PA 19044 (phone: 215-707-4936; e-mail: mmancano@temple.edu). Your report will be published anonymously unless otherwise requested. This feature is provided by the Institute for Safe Medication Practices (ISMP) in cooperation with the FDA's MedWatch program and Temple University School of Pharmacy. ISMP is an FDA MedWatch partner.

Entities:  

Year:  2017        PMID: 29276272      PMCID: PMC5735715          DOI: 10.1177/0018578717717621

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN: 0018-5787


  5 in total

1.  Risperidone-Associated Rhabdomyolysis Without Neuroleptic Malignant Syndrome: A Case Report.

Authors:  Mei Ling Look; Yang Liang Boo; Pek Woon Chin; Fan Kee Hoo
Journal:  J Clin Psychopharmacol       Date:  2017-02       Impact factor: 3.153

2.  Hypersalivation as an Adverse Drug Reaction Related to Lithium Carbonate: A Case Report.

Authors:  Rami Bou Khalil; Lama Souaiby; Roba Ghossan; Sami Richa
Journal:  J Clin Psychopharmacol       Date:  2016-12       Impact factor: 3.153

3.  Persistent life-threatening hemorrhage after administration of idarucizumab.

Authors:  Hussain M Alhashem; Carmen Avendano; Bryan D Hayes; Michael E Winters
Journal:  Am J Emerg Med       Date:  2016-06-30       Impact factor: 2.469

4.  Fluconazole-Induced Type 1 Kounis Syndrome.

Authors:  Hardeep Singh Mahal
Journal:  Am J Ther       Date:  2016 May-Jun       Impact factor: 2.688

5.  Incidence of Hyponatremia with High-Dose Trimethoprim-Sulfamethoxazole Exposure.

Authors:  Demetra Tsapepas; Mariana Chiles; Revekka Babayev; Maya K Rao; Manasvi Jaitly; David Salerno; Sumit Mohan
Journal:  Am J Med       Date:  2016-08-16       Impact factor: 4.965

  5 in total
  1 in total

1.  [Rhabdomyolysis under treatment with venlafaxine and risperidone].

Authors:  R Weisser; S Jalili; E Haen; W Schulte-Mattler; T C Wetter
Journal:  Nervenarzt       Date:  2020-02       Impact factor: 1.214

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.